Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains
- PMID: 27079292
- PMCID: PMC5322813
- DOI: 10.1111/jth.13338
Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains
Abstract
Essentials C57BL/6J-tissue plasminogen activator (tPA)-deficient mice are widely used to study tPA function. Congenic C57BL/6J-tPA-deficient mice harbor large 129-derived chromosomal segments. The 129-derived chromosomal segments contain gene mutations that may confound data interpretation. Passenger mutation-free isogenic tPA-deficient mice were generated for study of tPA function.
Summary: Background The ability to generate defined null mutations in mice revolutionized the analysis of gene function in mammals. However, gene-deficient mice generated by using 129-derived embryonic stem cells may carry large segments of 129 DNA, even when extensively backcrossed to reference strains, such as C57BL/6J, and this may confound interpretation of experiments performed in these mice. Tissue plasminogen activator (tPA), encoded by the PLAT gene, is a fibrinolytic serine protease that is widely expressed in the brain. A number of neurological abnormalities have been reported in tPA-deficient mice. Objectives To study genetic contamination of tPA-deficient mice. Materials and methods Whole genome expression array analysis, RNAseq expression profiling, low- and high-density single nucleotide polymorphism (SNP) analysis, bioinformatics and genome editing were used to analyze gene expression in tPA-deficient mouse brains. Results and conclusions Genes differentially expressed in the brain of Plat(-/-) mice from two independent colonies highly backcrossed onto the C57BL/6J strain clustered near Plat on chromosome 8. SNP analysis attributed this anomaly to about 20 Mbp of DNA flanking Plat being of 129 origin in both strains. Bioinformatic analysis of these 129-derived chromosomal segments identified a significant number of mutations in genes co-segregating with the targeted Plat allele, including several potential null mutations. Using zinc finger nuclease technology, we generated novel 'passenger mutation'-free isogenic C57BL/6J-Plat(-/-) and FVB/NJ-Plat(-/-) mouse strains by introducing an 11 bp deletion into the exon encoding the signal peptide. These novel mouse strains will be a useful community resource for further exploration of tPA function in physiological and pathological processes.
Keywords: brain; congenic mice; gene targeting; mutation; tissue plasminogen activator.
© 2016 International Society on Thrombosis and Haemostasis.
Figures



Comment in
-
Backseat drivers: passenger mutations take control of experimental phenotypes.J Thromb Haemost. 2016 Aug;14(8):1615-7. doi: 10.1111/jth.13373. Epub 2016 Jul 27. J Thromb Haemost. 2016. PMID: 27214856 No abstract available.
Similar articles
-
Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.Arterioscler Thromb Vasc Biol. 2014 May;34(5):1093-101. doi: 10.1161/ATVBAHA.113.302088. Epub 2014 Feb 27. Arterioscler Thromb Vasc Biol. 2014. PMID: 24578379 Free PMC article.
-
Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice.Immunity. 2015 Jul 21;43(1):200-9. doi: 10.1016/j.immuni.2015.06.011. Epub 2015 Jul 7. Immunity. 2015. PMID: 26163370 Free PMC article.
-
Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation.Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1571-1580. doi: 10.1167/iovs.18-25698. Invest Ophthalmol Vis Sci. 2019. PMID: 30995314 Free PMC article.
-
The story of an exceptional serine protease, tissue-type plasminogen activator (tPA).Rev Neurol (Paris). 2016 Mar;172(3):186-97. doi: 10.1016/j.neurol.2015.10.002. Epub 2015 Nov 25. Rev Neurol (Paris). 2016. PMID: 26626577 Review.
-
Tissue plasminogen activator in the amygdala: a new role for an old protease.J Physiol Pharmacol. 2008 Dec;59 Suppl 8:135-46. J Physiol Pharmacol. 2008. PMID: 19258671 Review.
Cited by
-
Physiological and metabolic features of mice with CRISPR/Cas9-mediated loss-of-function in growth hormone-releasing hormone.Aging (Albany NY). 2020 May 18;12(10):9761-9780. doi: 10.18632/aging.103242. Epub 2020 May 18. Aging (Albany NY). 2020. PMID: 32422607 Free PMC article.
-
PKCδ-positive GABAergic neurons in the central amygdala exhibit tissue-type plasminogen activator: role in the control of anxiety.Mol Psychiatry. 2022 Apr;27(4):2197-2205. doi: 10.1038/s41380-022-01455-4. Epub 2022 Feb 10. Mol Psychiatry. 2022. PMID: 35145231
-
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity.J Neuroinflammation. 2025 Jan 14;22(1):8. doi: 10.1186/s12974-025-03336-3. J Neuroinflammation. 2025. PMID: 39810216 Free PMC article.
-
tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.Semin Thromb Hemost. 2017 Mar;43(2):154-168. doi: 10.1055/s-0036-1586229. Epub 2016 Sep 27. Semin Thromb Hemost. 2017. PMID: 27677179 Free PMC article. Review.
-
Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.Transl Stroke Res. 2022 Oct;13(5):801-815. doi: 10.1007/s12975-022-00992-y. Epub 2022 Feb 4. Transl Stroke Res. 2022. PMID: 35122213 Free PMC article.
References
-
- Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. The Journal of biological chemistry. 1994;269:27155–8. - PubMed
-
- Vanden Berghe T, Hulpiau P, Martens L, Vandenbroucke RE, Van Wonterghem E, Perry SW, Bruggeman I, Divert T, Choi SM, Vuylsteke M, Shestopalov VI, Libert C, Vandenabeele P. Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. Immunity. 2015;43:200–9. 10.1016/j.immuni.2015.06.011. - PMC - PubMed
-
- Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, Newton K, Qu Y, Liu J, Heldens S, Zhang J, Lee WP, Roose-Girma M, Dixit VM. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479:117–21. 10.1038/nature10558. - PubMed
-
- Collen D, Lijnen HR. The fibrinolytic system in man. Crit Rev Oncol Hematol. 1986;4:249–301. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous